Neoadjuvant Treatment of Pancreatic Cancer: Borderline-Resectable Disease

Gauri R Varadhachary, Christopher Crane, Eric P. Tamm, Huamin Wang, Robert A. Wolff, Douglas B. Evans

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationThe Pancreas
Subtitle of host publicationAn Integrated Textbook of Basic Science, Medicine, and Surgery: Second Edition
PublisherBlackwell Publishing Ltd
Pages727-740
Number of pages14
ISBN (Print)9781405146647
DOIs
StatePublished - Feb 4 2009

Keywords

  • American Joint Committee on Cancer (AJCC) tumor
  • Anderson criteria for borderline-resectable pancreatic cancer
  • Endoscopic retrograde cholangiopancreatography (ERCP)-related pancreatitis
  • Gastrointestinal Tumor Study Group (GITSG)
  • Molecular targeted therapy
  • Multimodality treatment sequencing
  • National Comprehensive Cancer Network (NCCN)
  • Neoadjuvant treatment of pancreatic cancer - borderline-resectable disease
  • Short-segment involvement of common hepatic artery (CHA)

ASJC Scopus subject areas

  • General Medicine

Cite this